Development
HCA Healthcare, Inc.
HCA
$376.86
$4.411.18%
NYSE
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Net Income | 48.93% | -9.56% | -12.47% | -34.50% | 83.51% |
| Total Depreciation and Amortization | 2.60% | 0.79% | 0.93% | 0.80% | 0.13% |
| Total Amortization of Deferred Charges | 0.00% | 12.50% | -11.11% | 28.57% | 0.00% |
| Total Other Non-Cash Items | 40.23% | 1,238.71% | -104.32% | 402.53% | -162.20% |
| Change in Net Operating Assets | -184.01% | -50.37% | 152.02% | -1,308.11% | -109.88% |
| Cash from Operations | 7.87% | 0.16% | 37.27% | -28.65% | -16.32% |
| Capital Expenditure | -1.05% | 7.57% | -3.68% | 9.52% | -16.98% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -125.48% | -1,644.44% | 92.17% | -139.58% | 20.00% |
| Divestitures | -9.09% | 57.14% | -95.76% | -71.79% | -7.44% |
| Other Investing Activities | -394.74% | -35.71% | -250.00% | 42.86% | -153.85% |
| Cash from Investing | -21.72% | -4.38% | -9.21% | -45.15% | -45.24% |
| Total Debt Issued | 100.00% | -99.90% | 59.52% | 779.43% | 115.33% |
| Total Debt Repaid | -45.99% | 117.76% | -245.09% | -416.09% | 155.41% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | 20.18% | -24.59% | -8.16% | 44.31% | -117.62% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 1.23% | 1.22% | 6.29% | -12.18% | 2.50% |
| Other Financing Activities | 8.28% | 15.08% | 49.49% | 17.57% | -112.44% |
| Cash from Financing | 8.22% | 5.51% | -65.24% | 60.55% | 20.67% |
| Foreign Exchange rate Adjustments | 200.00% | -- | -100.00% | -46.15% | 181.25% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 51.72% | 45.00% | 130.30% | 27.47% | -164.54% |